# Verastem Inc. (VSTM) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $8.20, market value $743 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Verastem Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 24.0×**. Each dollar of revenue is priced at 24.0×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 8.8×**. The shares trade at 8.8× book value; most of the value is in earnings power and intangibles rather than the balance sheet.

## Profitability
- **Operating margin: -550.3%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -677.6%**. The company reported a net loss over the last twelve months.
- **Return on equity: -366.2%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 125.5%**. Return on all capital, debt included, is 125.5%: comfortably above what that capital costs.
- **Return on assets: -85.0%**. Each dollar of assets produces -85.0% of profit.

## Growth
- **Revenue growth (1 yr): 209.1%** (3-yr 128.4%/yr, 5-yr -19.0%/yr). Revenue grew 209.1% over the last year, against -19.0% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 17.5%**. Earnings per share rose 17.5%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.71**. Debt is 0.71 times equity, moderate leverage.
- **Current ratio: 3.09** (quick 3.09). Current assets cover the next year's liabilities 3.09 times.
- **Altman Z-score: 1.26**. A Z-score of 1.26 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Verastem Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -22.3%** (YTD 6.2%, 3-mo 121.0%). The shares are down 22.3% over twelve months including dividends.
- **From 52-week high: -24.2%** (139.1% above the low). Trading 24% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 73**. An RSI of 73 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 1.25** (volatility 74%). Beta of 1.25 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=VSTM · Page: https://foliofundamentals.com/stocks/vstm

Not investment advice.